⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHVN News
Biohaven Ltd.
Bexorg Appoints Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors
globenewswire.com
PFE
BHVN
Global Spinocerebellar Ataxias - Pipeline Insight, 2026 | RNA-Based and Gene-Targeted Therapies Drive Licensing, Partnership, and Investment Opportunities
globenewswire.com
BHVN
Form 8-K
sec.gov
BHVN
Form 8-K
sec.gov
BHVN
Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidate BHV-1300 in Phase 3 for Graves' Disease
prnewswire.com
BHVN
Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026
prnewswire.com
BHVN
Biohaven Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Biohaven (BHVN)
prnewswire.com
BHVN
BHVN Investor Alert: Levi & Korsinsky Investigates Biohaven Ltd. (BHVN) For Potential Securities Fraud
accessnewswire.com
BHVN
Biohaven Ltd. (BHVN) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
BHVN
Form 8-K
sec.gov
BHVN